IZALTREO Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for IZALTREO with the United States Patent and Trademark Office. The USPTO has given the IZALTREO trademark a serial number of 86451138. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 23, 2018. This trademark is owned by Glaxo Group Limited. The IZALTREO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
izaltreo

General Information

Serial Number86451138
Word MarkIZALTREO
Filing DateTuesday, November 11, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 23, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, July 23, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 18, 2017EXTENSION 5 GRANTED
Wednesday, November 8, 2017EXTENSION 5 FILED
Wednesday, November 8, 2017TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 4 GRANTED
Tuesday, June 13, 2017EXTENSION 4 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016EXTENSION 3 GRANTED
Thursday, December 1, 2016EXTENSION 3 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 3, 2016EXTENSION 2 GRANTED
Tuesday, May 31, 2016EXTENSION 2 FILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Friday, November 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2015EXTENSION 1 GRANTED
Wednesday, November 18, 2015EXTENSION 1 FILED
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 14, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

izaltreo pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological